Neuroscience
Amitriptyline
11%
Basal Ganglia
5%
Beck Depression Inventory
16%
Cerebral Edema
11%
Clonidine
11%
Cranial Nerve
5%
Creutzfeldt Jakob Disease
11%
Delphi Method
11%
Dopamine Agonist
5%
Dopaminergic
11%
Dyspnea
11%
Essential Tremor
11%
Evoked Brain Stem Auditory Response
5%
Eyelid Reflex
5%
Fluoxetine
11%
Hydrocephalus
11%
ICD-10
23%
Impulse Control Disorder
11%
L-DOPA
6%
Magnetic Resonance Imaging
5%
Meningitis
11%
Mental Deterioration
11%
Migraine
5%
Neuroleptic Malignant Syndrome
11%
Nomogram
7%
Obsessive-Compulsive Disorder
9%
Parkinson's Disease
100%
Parkinsonism
16%
Pathological Gambling
11%
Primidone
11%
Psychometrics
11%
Pulmonary Edema
11%
Severe Depression
5%
Sleep Disorder
5%
Somatics
11%
Stereotypic Movement Disorder
26%
Transient Global Amnesia
11%
Tremor
11%
Valerian
11%
Viral Encephalitis
11%
Nursing and Health Professions
Alzheimer's Disease
11%
Barthel Index
5%
Brain Edema
11%
Cathepsin D
11%
Chi Square Test
15%
Chronic Tension Headache
11%
Clonidine
11%
Concurrent Validity
11%
Convergent Validity
17%
Cronbach Alpha Coefficient
9%
Cross-Sectional Study
9%
Disability
11%
Disease Severity
11%
Essential Tremor
11%
Gold Standard
7%
Hamilton Depression Rating Scale
5%
Health Status
5%
Hospital Anxiety and Depression Scale
18%
Inflammation
11%
Internal Consistency
16%
Item Total Correlation
7%
Loneliness
7%
Mental Deterioration
11%
Migraine
11%
Motor Dysfunction
16%
Multiple Linear Regression Analysis
12%
Myelodysplastic Syndrome
11%
Neurocysticercosis
11%
Parkinson's Disease
53%
Quality of Life
5%
Rating Scale
11%
Satisfaction with Life Scale
11%
Scanning Electron Microscopy
5%
Short Portable Mental Status Questionnaire
19%
Tension Headache
8%
Unified Parkinson's Disease Rating Scale
23%
Medicine and Dentistry
Altitude Disease
11%
Alzheimer's Disease
11%
Barthel Index
5%
Brain Edema
11%
Cathepsin D
11%
Chi Square Test
11%
Creutzfeldt-Jakob Disease
11%
Cross Sectional Study
5%
Diabetes Mellitus
11%
Disability
11%
DNA Polymorphism
11%
Drug Megadose
11%
Effect Size
5%
Essential Tremor
11%
Glutamate Receptor Antagonist
5%
Harmaline
11%
Harmine
5%
Health Status
5%
Huntington's Disease
11%
Hypoxia
8%
Levodopa
11%
Loneliness
7%
Medication Compliance
6%
Metabolic Regulation
8%
Migraine
5%
Minimal Clinically Important Difference
11%
Multiple Linear Regression Analysis
12%
Nausea
5%
Neurocysticercosis
11%
Neuroleptic Malignant Syndrome
11%
Onychomycosis
8%
Parkinson's Disease
11%
Parkinsonism
5%
Patient Compliance
11%
Patient with Diabetes
11%
Primidone
11%
Pulmonary Edema
11%
Rapid Assessment
11%
Satisfaction with Life Scale
11%
Self Concept
5%
Treatment of Parkinson's Disease
5%
Unified Parkinson's Disease Rating Scale
5%
